This proposal came as 23andMe's valuation plummeted from $6 billion in 2021 to under $150 million. The company has faced ...

With 23andme in a desperate situation and eyeing a potential sale, Medical Device Network examines what is set to happen to ...

Over the past year, 23andMe set new corporate governance lows. CEO Anne Wojcicki now enters de facto “founder mode” after a ...

Stock splits are typically viewed as bullish indicators that a company sees more growth is on the horizon. Although nothing ...

Me helped usher in the era of consumer DNA test kits nearly two decades ago, but has more recently faced a series of setbacks ...

A spokesperson for 23andMe would not comment to NPR on what will happen to genetic data, except to express the company’s ...

Anne Wojcicki, the CEO of the consumer genetic testing company 23andMe (ME), is cautiously optimistic about the firm’s future ...

A huge data breach followed by a plummeting valuation has stoked fears of a sale of 23andMe along with all of its customers' genetic data.

Here's how to delete your data as company shake-up leaves customers wondering what will happen to their DNA info.

Here is a look at why companies split their stocks and why stock splits matter. Plus, upcoming splits to watch from 23andMe ...

SUNNYVALE, Calif., Oct. 16, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (the “Company” or “23andMe”), announced today the ...